disodium [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-2H,3H,4H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl phosphonato]oxy}phosphonate

• ChemBase编号: 295326
• 分子式: C27H31N9Na2O15P2
• 平均质量: 829.513402
• 单一同位素质量: 829.12102316
• SMILES: [Na+].[Na+].O=c1c2nc3cc(c(cc3n(c2nc(=O)[nH]1)C[C@H](O)[C@H](O)[C@H](O)COP(=O)([O-])OP(=O)([O-])OC[C@H]1O[C@@H](n2cnc3c(ncnc23)N)[C@H](O)[C@@H]1O)C)C
• Canonical SMILES: O=c1[nH]c(=O)c2c(n1)n(C[C@@H]([C@@H]([C@@H](COP(=O)(OP(=O)(OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc3c1ncnc3N)[O-])[O-])O)O)O)c1c(n2)cc(c(c1)C)C.[Na+].[Na+]
• InChI: InChI=1S/C27H33N9O15P2.2Na/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36;;/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43);;/q;2*+1/p-2/t14-,15+,16+,19-,20+,21+,26+;;/m0../s1
• InChIKey: XLRHXNIVIZZOON-WFUPGROFSA-L

名称和登记号

名称

• IUPAC标准名: disodium [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-2H,3H,4H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl phosphonato]oxy}phosphonate
• IUPAC传统名: disodium [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-3H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl phosphonato]oxyphosphonate
• 别名: 黄素腺嘌呤二核甘酸钠水合物; FAD-Na2; Riboflavin 5'-adenosine diphosphate disodium salt; Flavin adenine dinucleotide disodium salt hydrate

登记号

• CAS号: 84366-81-4
• EC号: 282-733-8
• MDL号: MFCD00151217
• PubChem SID: 180680857
• PubChem CID: 2734019

理论计算性质

• Acid pKa: 1.8570336
• 质子受体: 19
• 质子供体: 7
• LogD (pH = 5.5): -7.1269007
• LogD (pH = 7.4): -7.9570637
• Log P: -5.519229
• 摩尔折射率: 175.1874 cm^3
• 极化性: 67.83721 Å^3
• 极化表面积: 362.08 Å^2
• 可自由旋转的化学键: 13
• 里宾斯基五规则: false

分子性质

安全信息

• TSCA收录: 否

产品相关信息

• 纯度: 94% (dry wt.), water <10%